Charles River Laboratories International Inc.

Charles River Laboratories International Inc.

CRL

Market Cap$10.86B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Charles River Laboratories International Inc.Charles River Laboratories International Inc.24.40%12%2.70.7
$264.80

Target Price by Analysts

22.5% upsideCharles River Laboratories International Target Price DetailsTarget Price
$174.65

Current Fair Value

19.2% downside

Overvalued by 19.2% based on the discounted cash flow analysis.

Share Statistics

Market cap$10.86 Billion
Enterprise Value$13.20 Billion
Dividend Yield$0.0 (0.0%)
Earnings per Share$8.62
Beta1.44
Outstanding Shares51,511,687
Avg 30 Day Volume423,474

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio24.44
PEG-83.54
Price to Sales2.74
Price to Book Ratio3.09
Enterprise Value to Revenue3.21
Enterprise Value to EBIT22.94
Enterprise Value to Net Income29
Total Debt to Enterprise0.2
Debt to Equity0.73

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Charles River Laboratories International Inc.

17,000 employees
CEO: James Foster

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our...